Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
08/2005
08/11/2005US20050175543 Agents for magnetic imaging method
08/11/2005US20050175541 Enhanced drug delivery
08/10/2005EP1561425A1 Indocyanine dyes
08/10/2005EP1084145B1 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis
08/10/2005EP0894009B1 Improved vision through photodynamic therapy of the eye
08/10/2005EP0776175B1 Therapeutic homeopathic dilutions of growth factors and use
08/10/2005CN1652831A Electrocardiographic aspects of CHF treatment
08/10/2005CN1652804A Method for extended storage of blood and blood components
08/06/2005CA2470403A1 Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders
08/06/2005CA2457214A1 Photodynamic therapy for the treatment of acne
08/04/2005WO2005058889A3 Biological active blood serum obtained by electrostimulation
08/04/2005WO2005051305A3 Enhanced drug delivery
08/04/2005WO2005037259A3 Methods and compositions for the prevention or treatment of neoplasia comprising a cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist
08/04/2005US20050169944 Administering ozone to reduce hypoxia; enhancing drug or radio therapy
08/03/2005EP1559374A1 Cyanine dyes
08/03/2005EP1558616A2 Meso-substituted porphyrins
08/03/2005EP1359975A4 Ocular iontophoretic device and method of use
08/03/2005EP0702719B1 Process for the sterilization of biological compositions and the product produced thereby
08/03/2005CN1649585A Epothilone derivative for the treatment of hepatoma and other cancer diseases
08/03/2005CN1649584A Antibacterial compositions comprising metal phthalocyanine analogues
08/03/2005CN1649583A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
08/02/2005US6924284 PARP inhibitors
08/02/2005US6923955 Prophylaxis and/or reversing presbyopia by applying localized energy to area to be treated and administering biologically acceptable chemical substance capable of breaking chemical bonds such as disulfide bonds between cortical lens fibers
07/2005
07/28/2005WO2004080284A9 Antibody-targeted photodynamic therapy
07/28/2005US20050165393 Microporation of tissue for delivery of bioactive agents
07/28/2005US20050163778 Extracorporeal photopheresis in combination with anti-TNF treatment
07/28/2005US20050163716 Methods of preparing gaseous precursor-filled microspheres
07/27/2005EP1556061A2 Photokinetic delivery of biologically active substances using pulsed incoherent light
07/27/2005EP1555948A2 Phototreatment device for use with coolants and topical substances
07/27/2005EP0935462B1 Photopheresis treatment of leukocytes
07/27/2005CN2712931Y Electromagnetic cleavage device for cleavage extracting polypeptide from vegetable protein
07/27/2005CN1646174A Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
07/27/2005CN1646164A Process for the preparation of a nutrient formulation
07/27/2005CN1646097A Chemosensitizing with liposomes containing oligonucleotides
07/26/2005US6922578 Integrated poration, harvesting and analysis device, and method therefor
07/21/2005WO2005065282A2 Remote magnetically induced treatment of cancer
07/21/2005US20050159401 Treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation; forming a complexes with a reducing agent, penetrate and accumulate more rapidly in tumor cells, plaque, increase drug in intracellular concentration; increase photosensitivity
07/21/2005US20050158290 Process for the preparation of a nutrient formulation
07/21/2005US20050156147 Two-photon polymerizable composition and process for polymerization thereof
07/20/2005CN1211127C Nanoscale particles having iron oxide-containing core enveloped by at least two shells
07/19/2005US6919327 Texaphyrin coordination compounds and uses thereof
07/19/2005US6919179 Generating labeled proteins; obtain nucleotide sequences, incubate with cell free translation system, recover labeled protein
07/14/2005WO2005063306A1 Assembly of gas-filled microvesicle with active component for contrast imaging
07/14/2005WO2005063305A1 Gas-filled microvesicle assembly for contrast imaging
07/14/2005WO2005034855A3 Photodynamic inactivation of bacterial spores
07/14/2005US20050154049 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis
07/14/2005US20050153961 to hypoxic tumor cells and aerobic cells following or preceding a hypoxic incubation of the cells with the drug; ability to kill hypoxic cells directly; in vitro and in vivo; substitution in position 3 determines desired activity for compound
07/14/2005US20050152960 Photodynamic therapy; age-related macular degeneration; liposomes
07/14/2005CA2547024A1 Gas-filled microvesicle assembly for contrast imaging
07/14/2005CA2545362A1 Assembly of gas-filled microvesicle with active component for contrast imaging
07/13/2005EP1551461A2 Azo compounds for type i phototherapy
07/13/2005EP1551454A1 Protein production
07/13/2005CN1639178A Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
07/13/2005CN1639154A Pyranones useful as ATM inhibitors
07/13/2005CN1210020C Use of biodegradable microspheres for delivery of anticancer for treatment of glioblastoma
07/12/2005US6916810 αν integrin receptor antagonists
07/12/2005US6916800 Gelatinase inhibitors; anticancer agents
07/07/2005WO2005061518A1 Mitotic kinesin inhibitors
07/07/2005WO2005030253A3 Photocleavable dna transfer agent
07/07/2005US20050148772 Methods and compositions for detecting polynucleotide duplex damage and errors
07/07/2005DE10346950A1 Four-component herbal composition in form of capsules, useful for long-term, pre- or post-operative treatment of malignant tumors
07/07/2005CA2551543A1 Method of suppressing cancer
07/07/2005CA2547746A1 Mitotic kinesin inhibitors
07/06/2005EP1550454A1 Extracorporeal photopheresis in combination with anti-TNF treatment
07/06/2005EP1549320A1 Therapeutic combinations of erb b kinase inhibitors and antineoplastic therapies
07/06/2005EP1490315A4 Controlling chemical reactions by spectral chemistry and spectral conditioning
07/06/2005EP1044001B1 Integrin receptor antagonists
07/06/2005CN1635907A Topical compositions and methods for treatment of adverse effects of ionizing radiation
07/06/2005CN1635878A Methods of treating cancer and the pain associated therewith with using endothelin antagonists
07/06/2005CN1209172C Method for providing cosmetic/medical therapy
07/05/2005US6914078 Triarylmethane derivatives and their use as photochemotherapeutic agents
07/05/2005US6913914 Yeast culture capable of normalizing serum glutamate-pyruvate transaminase (GPT) and/or reducing serum hepatitis b surface antigen concentration for treating and preventing viral diseases; dietetics
07/05/2005US6913913 Methods and compositions for treating renal failure
06/2005
06/30/2005WO2005059118A2 Stem cell targeting using magnetic particles
06/30/2005WO2005058889A2 Biological active blood serum obtained by electrostimulation
06/30/2005WO2005058360A2 Radiation therapy and medical imaging using uv emitting nanoparticles
06/30/2005WO2005025508A3 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
06/30/2005WO2004112590A3 Methods of enhancing radiation effects with metal nanoparticles
06/30/2005US20050143466 drug delivery to infiltrate into spaces in skin; exposing skin to light energy to cause photosensitizing agent to become photodynamically activated; sebaceous gland disorder, sebum secretion, skin disorders
06/30/2005US20050143406 Use of e.g. 2-butylamino-2-demethoxy-hypocrellin B in sonodyamic therapy to treat cancer, skin disorders, infections, autoimmune diseases
06/30/2005US20050143315 N-[5-[[[5-[[[2-[(aminoiminomethyl)amino]ethyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]-4-[[[4-[(2-bromo-1-oxo-2-propenyl)amino]-1-methyl-1H-pyrrol-2-yl]carbonyl]amino]-1-methyl-1H-pyrrole-2-carboxamide hydrochloride having radiosensitisation activity
06/30/2005US20050142210 Thrombolytic agents and methods of treatment for thrombosis
06/30/2005US20050139485 applying a resonance conditioning frequencies, spectral energy pattern to a battery cell reaction system, act to accelerate and catalysis the reaction
06/30/2005CA2550084A1 Stem cell targeting using magnetic particles
06/30/2005CA2546979A1 A biological active blood serum, methods of producing it and uses thereof
06/29/2005EP1546203A2 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
06/29/2005EP1546168A2 Photoactivated anti-viral and anti-cancer agent
06/29/2005EP1545705A2 Flexible and/or elastic brachytherapy seed or strand
06/29/2005CN1633437A Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
06/28/2005US6911771 Coatings for low pressure discharge lamps comprising polysiloxanes embedded with glowing flakes, having heat resistance and flexibility
06/23/2005WO2005056058A2 Radiosensitizer conjugate to improve the efficacy of radiolabeled drugs
06/23/2005WO2005030254A3 Conjugates for photodynamic therapy
06/23/2005US20050137207 Inhibitor of prenylprotein tranferase for cancer and tumor treatment
06/23/2005US20050137180 Porphrins or azaporprins for photosensitizing therapy or photodetection with azaporprins for cardiovascular disorders and coordination with metals
06/23/2005US20050136102 Enhanced transport using membrane disruptive agents
06/23/2005CA2546057A1 Method to improve the efficacy of therapeutic radiolabeled drugs
06/23/2005CA2490218A1 Extracorporeal photopheresis in combination with anti-tnf treatment
06/22/2005EP1543119A2 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors
06/22/2005EP1381611B1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
06/22/2005EP1272200B1 Divided dose therapies with vascular damaging activity
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 95